ID A0A1I7Y932_9BILA Unreviewed; 1401 AA.
AC A0A1I7Y932;
DT 18-JAN-2017, integrated into UniProtKB/TrEMBL.
DT 18-JAN-2017, sequence version 1.
DT 27-MAR-2024, entry version 36.
DE SubName: Full=VWFA domain-containing protein {ECO:0000313|WBParaSite:L893_g13729.t2};
OS Steinernema glaseri.
OC Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC Tylenchina; Panagrolaimomorpha; Strongyloidoidea; Steinernematidae;
OC Steinernema.
OX NCBI_TaxID=37863 {ECO:0000313|Proteomes:UP000095287, ECO:0000313|WBParaSite:L893_g13729.t2};
RN [1] {ECO:0000313|WBParaSite:L893_g13729.t2}
RP IDENTIFICATION.
RG WormBaseParasite;
RL Submitted (NOV-2016) to UniProtKB.
CC -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR WBParaSite; L893_g13729.t2; L893_g13729.t2; L893_g13729.
DR Proteomes; UP000095287; Unplaced.
DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR CDD; cd00054; EGF_CA; 3.
DR Gene3D; 2.10.25.10; Laminin; 15.
DR Gene3D; 3.40.50.410; von Willebrand factor, type A domain; 1.
DR InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR InterPro; IPR013032; EGF-like_CS.
DR InterPro; IPR000742; EGF-like_dom.
DR InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR InterPro; IPR024731; EGF_dom.
DR InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR InterPro; IPR002035; VWF_A.
DR InterPro; IPR036465; vWFA_dom_sf.
DR PANTHER; PTHR24039; FIBRILLIN-RELATED; 1.
DR PANTHER; PTHR24039:SF28; FIBULIN-1; 1.
DR Pfam; PF12947; EGF_3; 4.
DR Pfam; PF07645; EGF_CA; 10.
DR Pfam; PF12661; hEGF; 1.
DR Pfam; PF00092; VWA; 1.
DR PRINTS; PR00453; VWFADOMAIN.
DR SMART; SM00181; EGF; 19.
DR SMART; SM00179; EGF_CA; 16.
DR SMART; SM00327; VWA; 1.
DR SUPFAM; SSF57196; EGF/Laminin; 5.
DR SUPFAM; SSF57184; Growth factor receptor domain; 2.
DR SUPFAM; SSF53300; vWA-like; 1.
DR PROSITE; PS00010; ASX_HYDROXYL; 15.
DR PROSITE; PS50026; EGF_3; 15.
DR PROSITE; PS50234; VWFA; 1.
PE 4: Predicted;
KW Disulfide bond {ECO:0000256|ARBA:ARBA00023157};
KW EGF-like domain {ECO:0000256|ARBA:ARBA00022536, ECO:0000256|PROSITE-
KW ProRule:PRU00076}; Repeat {ECO:0000256|ARBA:ARBA00022737}.
FT DOMAIN 22..61
FT /note="EGF-like"
FT /evidence="ECO:0000259|PROSITE:PS50026"
FT DOMAIN 101..280
FT /note="VWFA"
FT /evidence="ECO:0000259|PROSITE:PS50234"
FT DOMAIN 569..607
FT /note="EGF-like"
FT /evidence="ECO:0000259|PROSITE:PS50026"
FT DOMAIN 623..661
FT /note="EGF-like"
FT /evidence="ECO:0000259|PROSITE:PS50026"
FT DOMAIN 673..720
FT /note="EGF-like"
FT /evidence="ECO:0000259|PROSITE:PS50026"
FT DOMAIN 724..763
FT /note="EGF-like"
FT /evidence="ECO:0000259|PROSITE:PS50026"
FT DOMAIN 828..867
FT /note="EGF-like"
FT /evidence="ECO:0000259|PROSITE:PS50026"
FT DOMAIN 879..917
FT /note="EGF-like"
FT /evidence="ECO:0000259|PROSITE:PS50026"
FT DOMAIN 929..967
FT /note="EGF-like"
FT /evidence="ECO:0000259|PROSITE:PS50026"
FT DOMAIN 973..1011
FT /note="EGF-like"
FT /evidence="ECO:0000259|PROSITE:PS50026"
FT DOMAIN 1021..1059
FT /note="EGF-like"
FT /evidence="ECO:0000259|PROSITE:PS50026"
FT DOMAIN 1121..1168
FT /note="EGF-like"
FT /evidence="ECO:0000259|PROSITE:PS50026"
FT DOMAIN 1170..1209
FT /note="EGF-like"
FT /evidence="ECO:0000259|PROSITE:PS50026"
FT DOMAIN 1218..1257
FT /note="EGF-like"
FT /evidence="ECO:0000259|PROSITE:PS50026"
FT DOMAIN 1268..1316
FT /note="EGF-like"
FT /evidence="ECO:0000259|PROSITE:PS50026"
FT DOMAIN 1318..1356
FT /note="EGF-like"
FT /evidence="ECO:0000259|PROSITE:PS50026"
FT REGION 431..469
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 451..469
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ SEQUENCE 1401 AA; 154765 MW; AE92B449E49E7AA5 CRC64;
MEGFIDTSSQ YNLPPGRKCS NASNECLDKS LNTCSDNADC IDTADGYICQ CFTGFVDQSS
NAKLAPGHRP DVPHRXXXXN AKLAPGRVCE VDTLCGKQKT DLMFLIDGSG SIGSYVFKHE
VLRFVKEFVQ LFDIGLENTR VGLIQYSDQI RHEFDLNQYV DENSLQQAIA STQYLTGLTR
TGAAIQHMVM EGFSERRGAR PQSEEISRVA IVITDGRSQD NVTGPAIAAR KLHVNTFAIG
VTDHVLASEL ESIAGSPHRW FYVDRFKDLD TRLRSLIQKI ACPNKAPETQ PNVPCSVEKQ
TGCARELNER CESVASGETK CQCPGKFQRH PETRVCGGHQ CNPQLATSCP SPEVCAQTPF
GNHRCVCPDG XXXXACVEDT SATRSWLLLV RVPKCALRRP SATIAACVLM GTLGRFALDS
VNKRLESLND KNXXXXTPAR FAPDSVCPPP KSTSPNLQSS SNTTRTATTA ESSALQHDAD
CHNGGIQCGR HEQCLHERAS NSWSCQCSLG FERNYRTGEC VIPGSCDPAQ EGSCDLRKRE
RCLLHVSGRY HTCQCAAKER RHPVTEVCLR NECNDGGHDC DRSAKCVDTD DGFLCACPAG
FLDQSPDPSP DPVRRPGRLC VAEQNECAAG THRCSPHALC TDTPEGYVCR CKPGFVDFSP
NPHSIGGLVC KELVNECSAP HLNTCHRDAI CIDTMESYKC VCRPGFTDLD ELRSPGRNCQ
KVQHNERCLA GHNDCDRNAR CIQRGENDFV CACLPGFKDK SPDPSGRPGR VCIPVIPECD
NPTLNDCDSP DRALCTDTDD GYVCRCRQGF LDISPNIAQK PGRLCKPLEN ECAKGTDDCA
REGGICEDTP DSFTCRCAVN YLDVSFDRAS RPGRKCKRLV DECATGQNDC SPEAICTDTE
DSYVCACPNT YLDVSPDVAR KPGRRCLLRI NECAEGKHDC SPNADCQDTP ESFTCRCRDD
FVDDNPQRPX XXXINECAEG KHDCSPNADC QDTPESFTCR CRDDFVDDNP QRPGRVCRPA
LVDECRLGKH DCHRDAMCQD LPQGFSCQCR QGFLDESPHR VTQPGRVCVP RPTPPPDECR
LDNAASCKEA LNEVCRLLDG VPKCACPLNY ARDSRTRACT VIDECRFPQL NDCHPSAECV
DQPQGYSCRC RQGFKDLSPA GRAGRNCQPL VNECQFPHLN DCNLNARCID LEEGYDCKCN
SGFMDRNPSR PGRICQQMID ECARADLNSC DKNARCIDEE EGYRCECNAN FLDVSPSPTL
RGRACRPIVN ECADPKLNDC DRTAKCVDTM DSYQCQCPAN SKDISPNPAF PGRVCLVYEN
ECLTGKHDCD TNALCRDNEQ SFTCECKQGF TDRSPNKMTR PGRVCVEVST WEGLRTVFGC
LLFLRCCEWL TFSFKTEGCK V
//
